Australia, June 27 -- Disc Medicine Inc., owns the trademark (2616078) for 'DISC MEDICINE' till Nov. 19, 2035.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations for the treatment of erythropoietic porphyria (EPP), X-linked protoporphyria (XLPP), genetic diseases and disorders, dermatological diseases and disorders, hematological diseases and disorders, liver diseases and disorders, and photosensitivity.], 10 [Medical tools being devices for diagnosing erythropoietic protoporphyria; medical tools being devices for treating and diagnosing sun exposure.] and 42 [Research and development of pharmaceuticals and biologics for the treatment of immunologic disorders, hematologic disorders, anemia disorders, oncologic disorders and renal disorders; none of the foregoing offered in connection with treatment of diseases or disorders relating to spinal discs; scientific research and development in the field of sun exposure and related disease risk; research and development of pharmaceuticals, biologic preparations and medicines in the field of sun exposure and related disease risk; medical research and development in the field of sun exposure and related disease risk; conducting surveys and questionnaires being surveys to detect sun exposure and related disease risk.]
Type of Mark: Word
Date of Acceptance: Jan. 30
Registration Advertised: June 26
For further details contact Greenfield & Sacks P.C. Christina M. Licursi Wolf.
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2616078.
Disclaimer: Curated by HT Syndication.
